FORTRESS BIOTECH INC(NASDAQ:FBIO) stock News

FBIO Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Zacks Investment Research - Mentions: PAHC

Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates

2 days ago - By: Fortress Biotech, Inc.

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

4 days ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

8 days ago - By: Zacks Investment Research - Mentions: RPTX

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

9 days ago - By: Zacks Investment Research - Mentions: CHRS

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

9 days ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

3 months ago - By: Zacks Investment Research - Mentions: HRZN AFCG

New Strong Sell Stocks for May 16th

11 days ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

a month ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

2 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

2 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

2 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

2 months ago - By: Yahoo Finance - Mentions: TM DG MSCI ADT

Vanguard to add four more funds to investor proxy choice program

2 months ago - By: Yahoo Finance - Mentions: O FLS GTLS KIM ...

3 Reasons to Buy Realty Income Stock Like There's No Tomorrow

2 months ago - By: Yahoo Finance - Mentions: VNLA DD KKR STR ...

Janus Henderson Adds New Active Short Duration ETF in Europe

3 months ago - By: Fortress Biotech, Inc.

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

3 months ago - By: Yahoo Finance - Mentions: TTWO TMHC OMCL CAH ...

TTWO Earnings: Waiting for GTA VI

3 months ago - By: Zacks Investment Research - Mentions: CGEN

Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates

3 months ago - By: Fortress Biotech, Inc.

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

3 months ago - By: Zacks Investment Research - Mentions: DTIL

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: SCPH

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

3 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

3 months ago - By: Checkpoint Therapeutics, Inc - Mentions: CKPT

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

3 months ago - By: Zacks Investment Research - Mentions: WVE

Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates

3 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

3 months ago - By: Fortress Biotech, Inc.

Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

5 months ago - By: Zacks Investment Research - Mentions: GILD

Fortress Biotech (FBIO) Reports Q4 Loss, Lags Revenue Estimates

5 months ago - By: Fortress Biotech, Inc.

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

5 months ago - By: Checkpoint Therapeutics, Inc - Mentions: CKPT

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

5 months ago - By: Fortress Biotech, Inc.

Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

5 months ago - By: Julie & Holleman LLP - Mentions: CKPT

CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma

5 months ago - By: Benzinga - Mentions: CKPT

India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details

5 months ago - By: Journey Medical Corporation - Mentions: DERM

Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea

FORTRESS BIOTECH INC (FBIO) Stock News

FBIO Latest News, Press Relases and Analysis